News
CMND
2.490
-7.09%
-0.190
Psychedelic: Definium soars on study results for LSD-based depression treatment
TipRanks · 1d ago
Clearmind completes treatment for all participants in Part A of CMND-100 trial
TipRanks · 4d ago
Clearmind Medicine Completes Treatment For All Participants In Part A Of Ongoing Phase I/II Clinical Trial Evaluating CMND-100 For Treatment Of Alcohol Use Disorder
Benzinga · 4d ago
Clearmind completes Part A dosing in Phase I/II CMND-100 trial for alcohol use disorder
PUBT · 4d ago
CLEARMIND MEDICINE - PHASE I/II TRIAL CONDUCTED UNDER FDA OVERSIGHT IN U.S. AND ISRAEL
Reuters · 4d ago
Weekly Report: what happened at CMND last week (0615-0619)?
Weekly Report · 4d ago
Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial
Barchart · 4d ago
HRT Financial LP disposes of $73,191 in Clearmind Medicine common shares
PUBT · 06/18 21:06
Psychedelic: Clearmind completes Part A dosing for Phase I/II CMND-100 trial
TipRanks · 06/18 14:00
UPDATE: Clearmind Medicine Secures U.S. Patent Covering MEAI-Based Compositions And Methods For Regulating Binge Drinking, Eating, And Gambling Behaviors
Benzinga · 06/18 12:16
Clearmind Medicine Awarded U.S. Patent for Binge Behavior Regulators
Benzinga · 06/18 11:56
Clearmind Medicine wins US patent for MEAI-based binge behavior regulators
PUBT · 06/18 11:55
Clearmind Medicine Granted U.S. Patent for Binge Behavior Regulators
Barchart · 06/18 06:55
HRT Financial LP disposes of 2,102 Clearmind Medicine common shares worth $7,062.72
PUBT · 06/16 13:19
Clearmind Medicine completes dosing for four cohorts of CMND-100 trial
TipRanks · 06/16 11:45
Clearmind Medicine Completes Dosing Of All 24 Participants In Groups 1 To 4 Of Part A Of Its Phase I/II Clinical Study Of CMND-100 To Treat Alcohol Use Disorder
Benzinga · 06/16 11:36
Clearmind completes Part A dosing in Phase I/II CMND-100 trial for alcohol use disorder
PUBT · 06/16 11:32
CLEARMIND MEDICINE COMPLETES DOSING FOR PART A OF ITS OF FDA-REGULATED PHASE I/II CLINICAL TRIAL
Reuters · 06/16 11:32
Weekly Report: what happened at CMND last week (0608-0612)?
Weekly Report · 06/15 09:37
HRT Financial LP reports Clearmind Medicine common share disposal worth $27,699.99
PUBT · 06/12 20:29
More
Webull provides a variety of real-time CMND stock news. You can receive the latest news about Clearmind Medici through multiple platforms. This information may help you make smarter investment decisions.
About CMND
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.